TR201815876A2 - SPEAKING DIGITAL INSULIN PEN - Google Patents

Abstract

The invention relates to a talking digital insulin pen which enables visually impaired, illiterate or visually impaired elderly Type 1 and Type 2 diabetes patients using insulin pen to perform self-administration accurately and effectively. a body (13), the digital display (1) positioned on the body (13) such that the on-off switch (4) positioned on the body (13) is next to the on-off switch (4) will be at the bottom of the digital display (1). dose adjustment buttons (+ and -) (3) positioned on the body (13), injection button (2) associated to the right side surface of the body (13), audible warning system (5) positioned on the rear surface of the body (13), audible warning at least one battery (6) positioned on the rear surface of the housing (13) such that the loudspeaker (7) positioned on the rear surface of the housing (13) is positioned on the rear side of the housing (13) so that it is on the left side of the system (5). at least one motor (9) associated with the driving piston (10) sensing and adjusting the written dose on the right side of the driving piston (10) is associated with the left side of the driving piston (10). The loop insulin cartridge (11) comprises the needle (12) and the insulin pen cap (8) associated with the left side of the insulin cartridge (11).

Description

DESCRIPTION Technological Field: This invention is suitable for the blind, illiterate or visually impaired using an insulin pen. Insulin self-insulin in elderly Type 1 and Type 2 diabetes patients with reduced sense Talking digital insulin, which enables them to administer the drug accurately and effectively. It's about the pen.

State of the Art: Diabetes; due to the absence or deficiency of the hormone insulin released from the pancreas It is a chronic disease that develops as a lifelong and has a cure. Type 1 and Type 2 diabetes is divided into two. vital for patients with type 1 diabetes and insulin therapy that provides adequate metabolic control for Type 2 diabetes patients. It is very important. Diabetic retinopathy (DR), which is the most important cause of blindness all over the world, It is one of the most important complications of diabetes. Blindness compared to the general population The risk is 25 times higher in diabetic patients. In addition, Type 2 diabetes is usually 40 years old. These patients are usually elderly patients with reduced vision, since it occurs after is happening.

In recent years, patients have been able to use insulin injections on their own, due to its ease of use. ready for use as it is more reliable in dose adjustment prefers insulin pens. However, during the use of an insulin pen, the dose correct by visually impaired, elderly and elderly patients with reduced vision. cannot be adjusted, repeated use of the disposable needle attached to the pen, injection immediately before the entire dose of the needle passes through the skin into the subcutaneous tissue. removal (insufficient injection technique) creates significant problems.

Adjusting the correct dose, entering the skin at the right angle, and correct and timely removal of the needle from the skin after the injection procedure, Emphasis is placed on removing insulin from the pen after the procedure is finished. is being stopped.

If these steps are not taken into consideration, patients may experience hypoglycemia, hyperglycemia, injection site bleeding, bruising, insulin lipoatrophy and hypertrophy. complications may develop. To prevent these complications and In order for the patients to benefit from the treatment, they must have sufficient sense, knowledge and skills. or the properties of currently used insulin pens to prevent these complications. must have.

Dose adjustment in commonly used existing insulin pens is from the head of the pen. is adjusted manually. Dose with “fence” sound in every right-left turn increase is decreasing. The small amount on the head of the pen, numerically, increases and decreases the dose. one eye is followed. The needle is usually turned to the tip of the pen. is stuck. After the patient is started on insulin pen therapy, the doctor usually hands-on training by a diabetes nurse or a competent health professional It is given and the patient can self-inject with an insulin pen. is provided.

This is the case for elderly, visually impaired and illiterate patients. be able to inject himself and learn these methods makes it difficult. Today, this responsibility is usually done by patient relatives or caregivers. appears to be undertaken by the donors. A more effective drug with an insulin pen Assistive techniques that can be mounted on the insulin pen for administration developed.

In European patent application EP3188061A3 “Additional device and injected The injector system to monitor the amount is described. The invention in question is available on the market in lnsulog. It is sold under the brand name. The device is compatible with every insulin pen on the market. It is a device attached to a pen. Intelligent to automatically detect dosing action sensors are used and you can see how much insulin is taken and the last dosing time. shows with a screenshot. Using the built-in Bluetooth connection, you can Automatically a smart device for easy viewing and data sharing with physicians. aims to reach the phone application.

However, in this invention, a digital screen is an effective method of drug administration and notification. Although planned, elderly, visually impaired, visually impaired, reading There is no audible warning system for illiterate patients.

Chinese patent application CN201375731Y “Insulin with voice prompt function syringa” is explained. The invention includes an insulin syringe with a voice function.

By adding a voice recording to the widely used mechanical insulin pen, it can be used as a medical device. A useful feature has been added. In the mentioned invention, the dose is mechanical insulin dose regulation. It is adjusted by turning the knob and the value corresponding to the dose is heard from the speaker. is reported.

During injection, when the syringe needle enters the body, press the injection button. is printed in full. To remind remove the speaker pin after 10 seconds It gives a “tick” sound and the injection is completed.

In the above invention, elderly, visually impaired, visually impaired, literate There is an audible warning system for unfamiliar patients, but a digital display and There is no warning system that prevents repeated use of the needle.

In the patent application numbered TR201803977, “Application in insulin pens A timed, audible and light warning system to increase its effectiveness” is explained. Meet, The connection tip, which allows it to be attached to the insulin pen, ensures that the treatment application time time indicator and audible and illuminated warning signals. is formed.

In the mentioned invention, insulin therapy after pressing the injection button the application is started and when it is completed, the light signal is activated and the patient's makes it terminate the application. This invention is only for the patient's injection. It ensures that the entire dose can be delivered to the subcutaneous tissue during Blind, for elderly patients with reduced vision, audibly reporting the dose and the injection of insulin It does not have an audible notification to remind you to remove it from the pen.

In addition, many insulin pens on the market are used and thrown away when they are used up. Available inadequacy of the systems, the patients displace the insulin pen during administration. At variable times, it makes it difficult to follow the treatment of the patient and therefore and negatively affect the sugar order.

As a result, all domestic production, which will contribute to the country's economy, reduce costs and provide employment. A new technology is needed to create

Description of the Invention: This invention is a talking digital insulin pen and its feature is; blind, sense of sight elderly diabetic patients with reduced or illiteracy can use their own insulin pen to easily adjust the correct dose when self-injecting, to ensure that the application is correct to be terminated in time, after the application, use the disposable needle with a pen. is to ensure that it is removed from the injector without forgetting it.

Diabetes in the blind, impaired vision or illiterate elderly enable patients to effectively self-administer insulin provides ease of application, reduces the risk of complications, to increase comfort.

The invention, which is completely domestic production and contributes to the country's economy, It is a new technology that creates jobs.

Diabetes in the blind, visually impaired or illiterate elderly a superior system that enables the application to be performed more accurately and effectively for patients. It offers an insulin injector with features.

The patient is willing to use the standard application needle by attaching it to the tip of the insulin pen. is starting. Insulin pen whose digital screen is turned on from the on-off button You can easily select the dose to be administered by pressing the plus and minus buttons on the is setting. The numbers are easily visible on the screen and the dose can be increased. numbers are heard audibly. When the patient presses the plus (+) key 661.7 writes with numbers on the screen and a “one” sound is heard from the insulin pen. Dose is incremented one by one, and the number on the screen is spoken to each artist from the insulin pen. is heard.

When the required dose is set in the invention, the plunger of the pen will release the adjusted dose (prescribed dose). amount of insulin) is established to inject. patient application area select the insulin pen and press the big button next to the digital display of the insulin pen. is injecting. Normally, patients do not remove the needle after injecting. He is asked to count slowly until .

In the invention, the countdown starts from 10 on the screen after the injection and the time "Injection is complete, remove the needle" sound from the insulin pen when finished is heard. A few seconds after the needle is removed from the skin, the insulin pen The cap of the pen is closed and the device is turned off with the on/off button.

The invention is powered by a rechargeable battery. Insulin that is used and excreted Unlike pens, in this invention, the cartridge can be replaced when it runs out.

Thanks to the invention, elderly patients with visual impairment and impaired vision He can easily inject himself. Complications to occur Thanks to the decrease, the patient leads a better quality and more comfortable life.

The invention reduces health and care costs. Patients with hypoglycemia, hyperglycemia, injection site bleeding, bruising, insulin lipoatrophy and hypertrophy. It is also for health personnel who treat, care and follow-up by reducing complications. provides convenience.

The invention can easily be produced by companies that manufacture medical products in the industry. can be made and marketed.

Explanation of Figures: The invention will be described with reference to the accompanying figures so that the features of the invention will be more clearly understood and appreciated, but the purpose of this It's not about limiting yourself with regulations. On the contrary, the invention is satisfied by the appended claims. all alternatives, changes and It is intended to cover the equivalences. Details shown are present invention only shown for illustration of preferred embodiments and both methods formulation, as well as the rules and conceptual features of the invention. and it should be understood that they are presented to provide an easy-to-understand definition. This in drawings; Figure 1 is the front view of the invention.

Figure 2 is the rear view of the invention.

Figure 3 is the view of the insulin pen cap in the invention.

Figure 4 is a detailed front view of the invention.

Figures to assist in understanding this invention are as indicated in the attached picture. are numbered and given below with their names.

Explanation of References: 1. Digital display 2. Injection button 3. Dose adjustment keys (+ and -) 4. On-off button . Voice warning system 6. Battery 7. Speaker 8. Insulin pen cap 9. Engine . drive piston 11. Insulin cartridge 12. Needle 13. Body Description of the Invention: The invention is a body (13), on-off button (4) positioned on the body (13), on the body (13) next to the on-off button (4). positioned on the body so that the digital display (1) is at the bottom of the digital display (1). Dose adjustment keys (+ and -) (3) positioned on (13) are located on the right side of the body (13). The injection button (2) attached to the surface of the body (13) is placed on the rear surface of the body (13). the positioned voice warning system (5) will be to the left of the voice warning system (5) The loudspeaker (7) positioned on the rear surface of the body (13) as on the rear surface of the body (13) so that it is on the upper part of the system (5). positioned at least one battery (6), which detects the digitally written dose and so that the adjusting driver piston (10) is to the right of the driver piston (10). at least one associated engine (9), left side of the driving piston (10) the associated insulin cartridge (ll) from the left side of the insulin cartridge (ll) Consists of an associated needle (12) and an insulin pen cap (8) The invention has dose adjustment buttons (+) that allow the dose to be increased or decreased. and -) (3). Meet; dose, the end time of the administration and the administration includes an audible warning system (5) that reminds you to remove the needle at the end The invention is a device that detects the dose written digitally with the dose adjustment keys (+ and -) (3) and It has a driving piston (10) that adjusts. The invention is based on the digital display (1) and the audible warning system. (5) contains a rechargeable battery (6) that enables it to work. In addition, the invention digitally It has a motor (9) that will inject the entered dose (Figure-1, Figure-2, Figure-4).

Detailed Description of the Invention: Parts of the invention; body (13), digital display (1), injection button (2), dose adjustment keys (+ and -) (3), on-off button (4), buzzer (5), battery (6), speaker (7), insulin pen cap (8), motor (9), driver piston (10), insulin cartridge The operation of the invention is as follows. From the invention on-off button (4) is opening. The dose to be administered by pressing the dose adjustment buttons (+ and -) (3) When loading the insulin pen, the audible warning system (5) displays the numbers displayed on the digital screen (1). speaks aloud (Figure-1, Figure-2).

Thanks to the invention, when the injection button (2) is pressed and the application is completed, the needle (12) audible warning system to be removed from the skin (5) after 10 seconds enters. Thus, the entire dose is injected (Figure-1, Figure-2).

Thanks to the invention, it is possible to remove the disposable needle (12) after the application. In order to prevent the patient from being forgotten, the audible warning system (5) is activated and the needle (12) warns him to separate from the insulin pen. Sounds are behind the bass part of the device It is announced from the loudspeaker (7). Insulin pen after removal of needle (12) The cover (8) is closed and finally the device is released from the on/off button (4). is closing (Figure-2, Figure-4).

Claims (3)

REQUESTS The invention relates to the talking digital insulin pen, and its feature is; a body (13), the on-off button (4) positioned on the body (13) will be next to the on-off button (4), the digital display (1) positioned on the body (13) will be at the bottom of the digital display (1) Dose adjustment keys (+ and -) (3) positioned on the body (13) in the figure, injection button (2) attached to the right side surface of the body (13), audio warning system (5) positioned on the rear surface of the body (13), audible warning The loudspeaker (7) positioned on the rear surface of the body (13) to be on the left side of the system (5), at least one battery (6) positioned on the rear surface of the body (13) to be on the upper part of the audio warning system (5), digitally Driver piston (10) that detects and adjusts the prescribed dose, at least one motor (9) associated to the right side of the driver piston (10), insulin cartridge (l 1) associated with the left side of the driver piston (10), insulin cartridge (l) 1) the needle associated with the left side (1 2) and insulin pen cap (8). It is the talking digital insulin pen mentioned in claim 1, and its feature is; Dose adjustment keys (+ and -) that allow the dose to be applied can be adjusted and decreased ( 3) is characterized by having. It is the talking digital insulin pen mentioned in claim 1, and its feature is; It is characterized by the fact that it has a voice warning system (5) that reminds the dose, the end time of the application, the removal of the needle at the end of the application and the replacement of the disposable needle. It is the talking digital insulin pen mentioned in claim 3, and its feature is; It is characterized by the fact that the audible warning system (5) has a loudspeaker (7) that activates and enables the warning sound to be announced to the user. It is the talking digital insulin pen mentioned in claim 1, and its feature is; It is characterized by having a driver piston (10) that detects and adjusts the dose written digitally with the dose adjustment keys (+ and -) (3). It is the talking digital insulin pen mentioned in claim 1, and its feature is; It is characterized by having a rechargeable battery (6) that enables the digital display (1) and the audible warning system (5) to work. It is the talking digital insulin pen mentioned in claim 1, and its feature is; It is characterized by having a motor (9) that will inject the digitally entered dose.